Showing results (2061-2070 of 2,969) with videos related to
Sort By:
Pageof 297
Toxins|February 24, 2023
Combination Effect of Microcystins and Arsenic Exposures on CKD: A Case-Control Study in ChinaHong Gao, Na Zhu, Shuxiang Deng, et al.Immunological Investigations|September 7, 2025
TCR/BCR Secondary Rearrangement in Autoimmune Diseases: Molecular Mechanisms, Pathogenic Roles, and Therapeutic FrontiersFei Yang, Biao Zhang, Yi Liu, et al.Frontiers in Immunology|February 7, 2025
Efficacy and safety of PD-1 inhibitors as second-line treatment for advanced squamous esophageal cancer: a systematic review and network meta-analysis with a focus on PD-L1 expression levelsFei Yang, Min Dan, Jindan Shi, et al.Microbial Pathogenesis|January 25, 2024
The proteolytic activity in inflammatory bowel disease: insight from gut microbiotaJun-Jie Hou, Liang Ding, Tao Yang, et al.BMC Public Health|March 4, 2024
Factors associated with burnout among frontline nurses in the post-COVID-19 epidemic era: a multicenter cross-sectional studyShitao Wang, Guoshuai Luo, XiangQian Ding, et al.Applied and Environmental Microbiology|February 27, 2026
A novel approach to enhance methane production in anaerobic digestion of waste activated sludge via pre-enrichment by a microbial consortium of degrading fungiKun Dai, Xiao-Mei Zhu, Yan-Lin Hu, et al.The Science of the Total Environment|October 16, 2024
Simplification and simulation of evaluation process for low efficiency constructed wetlands based on principal component analysis and machine learningLei Xie, Jingjie Huang, Xiang Zhu, et al.Ecotoxicology and Environmental Safety|March 7, 2026
The pathophysiology of neurological risk from environmental toxins: Microcystin-LR leads to a decrease in neuron count via the pyroptosis pathway using brain organoid models and mouse modelsYing Liu, Qinmei Tan, Mei Yuan, et al.Frontiers in Pharmacology|June 26, 2026
Post-marketing safety evaluation of anthracycline for acute myeloid leukemia treatment: a real-world pharmacovigilance analysisYong Wang, Qian Liu, Jing Xu, et al.Anaesthesia, Critical Care & Pain Medicine|September 19, 2022
Median effective dose of 0.2% ropivacaine for ultrasound-guided median nerve block in young childrenWeiping Wang, Hang Chen, Shangyingying Li, et al.Pageof 297